Leurquin-Sterk Gil, Postnov Andrey, de Laat Bart, Casteels Cindy, Celen Sofie, Crunelle Cleo L, Bormans Guy, Koole Michel, Van Laere Koen
Division of Nuclear Medicine, KU Leuven - University of Leuven and University Hospital Leuven, Herestraat 49, Leuven, 3000, Belgium.
MoSAIC, Molecular Small Animal Imaging Center, KU Leuven - University of Leuven, Leuven, Belgium.
Synapse. 2016 Apr;70(4):153-62. doi: 10.1002/syn.21890. Epub 2016 Feb 8.
(18)F-FPEB is a promising PET tracer for studying the metabotropic glutamate subtype 5 receptor (mGluR5) expression in neuropsychiatric disorders. To assess the potential of (18)F-FPEB for longitudinal mGluR5 evaluation in patient studies, we evaluated the long-term test-retest reproducibility using various kinetic models in the human brain. Nine healthy volunteers underwent consecutive scans separated by a 6-month period. Dynamic PET was combined with arterial sampling and radiometabolite analysis. Total distribution volume (V(T)) and nondisplaceable binding potential (BP(ND)) were derived from a two-tissue compartment model without constraints (2TCM) and with constraining the K(1)/k(2) ratio to the value of either cerebellum (2TCM-CBL) or pons (2TCM-PONS). The effect of fitting different functions to the tracer parent fractions and reducing scan duration were assessed. Regional absolute test-retest variability (aTRV), coefficient of repeatability (CR) and intraclass correlation coefficient (ICC) were computed. The 2TCM-CBL showed best fits. The mean 6-month aTRV of V(T) ranged from 8 to 13% (CR < 25%) with ICC > 0.6 for all kinetic models. BPND from 2TCM-CBL with a sigmoid fit for the parent fractions showed the best reproducibility, with aTRV ≤ 7% (CR < 16%) and ICC > 0.9 in most regions. Reducing the scan duration from 90 to 60 min did not affect reproducibility. These results demonstrate for the first time that (18)F-FPEB brain PET has good long-term reproducibility, therefore validating its use to monitor mGluR5 expression in longitudinal clinical studies. We suggest a 2TCM-CBL with fitting a sigmoid function to the parent fractions to be optimal for this tracer.
(18)F - FPEB是一种很有前景的正电子发射断层扫描(PET)示踪剂,用于研究神经精神疾病中代谢型谷氨酸受体5(mGluR5)的表达。为了评估(18)F - FPEB在患者研究中纵向评估mGluR5的潜力,我们在人脑内使用各种动力学模型评估了长期重测重现性。9名健康志愿者接受了间隔6个月的连续扫描。动态PET与动脉采样和放射性代谢物分析相结合。总分布容积(V(T))和非置换性结合潜能(BP(ND))由无约束的双组织室模型(2TCM)以及将K(1)/k(2)比值约束为小脑(2TCM - CBL)或脑桥(2TCM - PONS)的值推导得出。评估了对示踪剂母体分数拟合不同函数以及缩短扫描持续时间的效果。计算了区域绝对重测变异性(aTRV)、重复性系数(CR)和组内相关系数(ICC)。2TCM - CBL显示出最佳拟合。所有动力学模型的V(T)的平均6个月aTRV范围为8%至13%(CR < 25%),ICC > 0.6。2TCM - CBL的BP(ND)对母体分数采用S形拟合显示出最佳重现性,大多数区域的aTRV≤7%(CR < 16%)且ICC > 0.9。将扫描持续时间从90分钟缩短至60分钟不影响重现性。这些结果首次证明(18)F - FPEB脑PET具有良好的长期重现性,从而验证了其在纵向临床研究中用于监测mGluR5表达的用途。我们建议对该示踪剂采用2TCM - CBL并对母体分数拟合S形函数为最佳方法。